Infections of the Central Nervous System after Unrelated Donor Umbilical Cord Blood Transplantation or Human Leukocyte Antigen-Matched Sibling Transplantation

被引:24
作者
Balaguer Rosello, Aitana [1 ]
Bataller, Luis [2 ]
Lorenzo, Ignacio [1 ]
Jarque, Isidro [1 ]
Salavert, Miguel [3 ]
Gonzalez, Eva [4 ]
Luis Pinana, Jose [1 ]
Sevilla, Teresa [2 ]
Montesinos, Pau [1 ]
Iacoboni, Gloria [1 ]
Muelas, Nuria [2 ]
Romero, Samuel [1 ]
Carretero, Carlos [1 ]
Montoro, Juan [1 ]
Jose Ibanez-Julia, Maria [2 ]
Sanz, Guillermo [1 ,5 ]
Angel Sanz, Miguel [1 ,5 ]
Sanz, Jaime [1 ,5 ]
机构
[1] Hosp Univ & Politecn La Fe, Dept Hematol, Valencia, Spain
[2] Hosp Univ & Politecn La Fe, Dept Neurol, Valencia, Spain
[3] Hosp Univ & Politecn La Fe, Dept Infect Dis, Valencia, Spain
[4] Hosp Univ & Politecn La Fe, Dept Microbiol, Valencia, Spain
[5] Univ Valencia, Dept Med, Valencia, Spain
关键词
Allogeneic stem cell transplantation; Umbilical cord blood; Infections; Encephalitis; Neurologic complications; STEM-CELL TRANSPLANTATION; HUMAN HERPESVIRUS-6 ENCEPHALITIS; BONE-MARROW-TRANSPLANTATION; NEUROLOGIC COMPLICATIONS; PERIPHERAL-BLOOD; LEUKEMIA; ADULTS; BUSULFAN; OUTCOMES; PROPHYLAXIS;
D O I
10.1016/j.bbmt.2016.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We analyzed the incidence, clinical characteristics, prognostic-factors, and outcome of central nervous system (CNS) infections in consecutive patients with receiving umbilical cord blood transplantation (UCBT) (n = 343) or HLA-matched sibling donor stem cell transplantation (MST) (n = 366). Thirty-four CNS infectioiis were documented at a median time of 116 days after transplantation (range, 7 to 1161). The cumulative incidence (CI) risk of developing a CNS infection was.6% at day +30, 2.3% at day +90, and 4.9% at 5 years. The 5-year CI of CNS infection was 8.2% after UCBT and 1.7% after MST (P<.001). The causative micro-organisms of CNS infections were fungi (35%), virus (32%), Toxoplasma spp. (12%), and bacteria (12%). Fungal infections occurred in 11 patients after UCBT and 1 after MST and were due to Aspergillus spp. (n = 8), Cryptococcus neoformans (n = 2), Scedosporium prolificans (n = 1), and Mucor (n = 1). Except for 1 patient, all died from CNS fungal infection. Viral infections occurred in 9 patients after UCBT and 1 after MST and were due to human herpes virus 6 (n = 7), cytomegalovirus (n = 2), and varicella zoster virus (n = 1). CNS toxoplasmosis was diagnosed in 3 patients after UCBT and 1 after MST. Other pathogens were Staphylococcus spp, Nocardia spp, Streptococcus pneumoniae, and Mycobacterium tuberculosis. Twenty of the 34 patients (59%) died from the CNS infection. In multivariable analysis, UCBT and disease stage beyond first complete remission were independently associated with the risk of developing CNS infections. The 5-year overall survival was 19% in patients who developed a CNS and 39% for those who did not (P =.006). In conclusion, our study showed that CNS infections are a significant clinical problem after stem cell transplantation associated with poor survival. They were more frequent after UCBT compared to MST. (C) 2017 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 32 条
[1]   Early neurologic complications following allogeneic bone marrow transplant for leukemia - A prospective study [J].
Antonini, G ;
Ceschin, V ;
Morino, S ;
Fiorelli, M ;
Gragnani, F ;
Mengarelli, A ;
Iori, AP ;
Arcese, W .
NEUROLOGY, 1998, 50 (05) :1441-1445
[2]   Early and Late Neurological Complications after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation [J].
Barba, Pere ;
Luis Pinana, Jose ;
Valcarcel, David ;
Querol, Luis ;
Martino, Rodrigo ;
Sureda, Anna ;
Briones, Javier ;
Delgado, Julio ;
Brunet, Salut ;
Sierra, Jorge .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (11) :1439-1446
[3]   Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases [J].
Bleggi-Torres, LF ;
de Medeiros, BC ;
Werner, B ;
Neto, JZ ;
Loddo, G ;
Pasquini, R ;
de Medeiros, CR .
BONE MARROW TRANSPLANTATION, 2000, 25 (03) :301-307
[4]   Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS [J].
de Lima, M ;
Couriel, D ;
Thall, PF ;
Wang, XM ;
Madden, T ;
Jones, R ;
Shpall, EJ ;
Shahjahan, M ;
Pierre, B ;
Giralt, S ;
Korbling, M ;
Russell, JA ;
Champlin, RE ;
Andersson, BS .
BLOOD, 2004, 104 (03) :857-864
[5]   Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group [J].
De Pauw, Ben ;
Walsh, Thomas J. ;
Donnelly, J. Peter ;
Stevens, David A. ;
Edwards, John E. ;
Calandra, Thierry ;
Pappas, Peter G. ;
Maertens, Johan ;
Lortholary, Olivier ;
Kauffman, Carol A. ;
Denning, David W. ;
Patterson, Thomas F. ;
Maschmeyer, Georg ;
Bille, Jacques ;
Dismukes, William E. ;
Herbrecht, Raoul ;
Hope, William W. ;
Kibbler, Christopher C. ;
Kullberg, Bart Jan ;
Marr, Kieren A. ;
Munoz, Patricia ;
Odds, Frank C. ;
Perfect, John R. ;
Restrepo, Angela ;
Ruhnke, Markus ;
Segal, Brahm H. ;
Sobel, Jack D. ;
Sorrell, Tania C. ;
Viscoli, Claudio ;
Wingard, John R. ;
Zaoutis, Theoklis ;
Bennett, John E. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1813-1821
[6]   A proportional hazards model for the subdistribution of a competing risk [J].
Fine, JP ;
Gray, RJ .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) :496-509
[7]   PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HIV-INFECTION [J].
GALLANT, JE ;
MOORE, RD ;
CHAISSON, RE .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (11) :932-944
[8]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[9]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[10]   Early central nervous system complications after reduced-intensity stem cell transplantation [J].
Kishi, Y ;
Miyakoshi, S ;
Kami, M ;
Ikeda, M ;
Katayama, Y ;
Murashige, N ;
Kusumi, E ;
Yuji, K ;
Kobayashi, K ;
Kato, D ;
Hamaki, T ;
Matsumura, T ;
Kim, SW ;
Morinaga, S ;
Mori, S ;
Kanemaru, M ;
Hayashi, T ;
Takaue, Y ;
Taniguchi, S .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (08) :561-568